$OSCE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CERAGENIX PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CERAGENIX PHARMACEUTICALS, INC.. Get notifications about new insider transactions in CERAGENIX PHARMACEUTICALS, INC. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 11 2010 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Sell | S | 0.25 | 60,000 | 15,000 | 12,162,170 | 12.2 M to 12.2 M (-0.49 %) |
Jun 13 2008 | OSCE | CERAGENIX PHARMACE ... | Bautista Alberto J | Director | Option Exercise | A | 0.73 | 48,000 | 35,040 | 48,000 | |
Jun 17 2008 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Option Exercise | S | 2.18 | 15,000 | 32,700 | 992,161 | |
Jun 13 2008 | OSCE | CERAGENIX PHARMACE ... | Porter Steven | Chief Executive Off ... | Option Exercise | A | 0.73 | 151,000 | 110,230 | 151,000 | |
Jun 13 2008 | OSCE | CERAGENIX PHARMACE ... | ALLEN RUSSELL L | Vice President | Option Exercise | A | 0.73 | 135,000 | 98,550 | 135,000 | |
Jun 13 2008 | OSCE | CERAGENIX PHARMACE ... | Hoffman Bray Cheryl A | Director | Option Exercise | A | 0.73 | 48,000 | 35,040 | 48,000 | |
Jun 13 2008 | OSCE | CERAGENIX PHARMACE ... | Sperber Jeffrey S | Chief Financial Off ... | Option Exercise | A | 0.73 | 135,000 | 98,550 | 135,000 | |
Jun 13 2008 | OSCE | CERAGENIX PHARMACE ... | GENBERG CARL | Senior Vice Preside ... | Option Exercise | A | 0.73 | 143,000 | 104,390 | 143,000 | |
Jun 13 2008 | OSCE | CERAGENIX PHARMACE ... | Gastone Philippe | Director | Option Exercise | A | 0.73 | 48,000 | 35,040 | 48,000 | |
Jun 13 2008 | OSCE | CERAGENIX PHARMACE ... | Darnaud Michel | Director | Option Exercise | A | 0.73 | 48,000 | 35,040 | 48,000 | |
May 19 2008 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Option Exercise | M | 4.00 | 1,000,000 | 4,000,000 | 0 | |
May 19 2008 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Buy | P | 0.00 | 1,304,569 | 0 | 12,222,170 | 10.9 M to 12.2 M (+11.95 %) |
Feb 12 2008 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Sell | S | 0.00 | 7,500 | 0 | 10,917,601 | 10.9 M to 10.9 M (-0.07 %) |
Aug 31 2007 | OSCE | CERAGENIX PHARMACE ... | Porter Steven | Chief Executive Off ... | Grant | A | 1.50 | 6,667 | 10,001 | 6,667 | 0 to 6.7 K |
Aug 31 2007 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Sell | S | 1.50 | 6,667 | 10,001 | 10,925,101 | 10.9 M to 10.9 M (-0.06 %) |
Aug 16 2007 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Sell | S | 1.25 | 10,000 | 12,500 | 10,931,768 | 10.9 M to 10.9 M (-0.09 %) |
Jun 08 2007 | OSCE | CERAGENIX PHARMACE ... | Porter Steven | Chief Executive Off ... | Option Exercise | A | 1.83 | 151,000 | 276,330 | 151,000 | |
Jun 29 2007 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Sell | S | 1.50 | 50,000 | 75,000 | 10,941,768 | 11 M to 10.9 M (-0.45 %) |
Jun 08 2007 | OSCE | CERAGENIX PHARMACE ... | Sperber Jeffrey S | Chief Financial Off ... | Option Exercise | A | 1.83 | 135,000 | 247,050 | 135,000 | |
Jun 08 2007 | OSCE | CERAGENIX PHARMACE ... | Hoffman Bray Cheryl A | Director | Option Exercise | A | 1.83 | 48,000 | 87,840 | 48,000 | |
Jun 08 2007 | OSCE | CERAGENIX PHARMACE ... | GENBERG CARL | Senior Vice Preside ... | Option Exercise | A | 1.83 | 143,000 | 261,690 | 143,000 | |
Jun 08 2007 | OSCE | CERAGENIX PHARMACE ... | Gastone Philippe | Director | Option Exercise | A | 1.83 | 48,000 | 87,840 | 48,000 | |
Jun 08 2007 | OSCE | CERAGENIX PHARMACE ... | Elias Peter | Chief Scientific Of ... | Option Exercise | A | 1.83 | 70,000 | 128,100 | 70,000 | |
Jun 08 2007 | OSCE | CERAGENIX PHARMACE ... | Darnaud Michel | Director | Option Exercise | A | 1.83 | 48,000 | 87,840 | 48,000 | |
Jun 08 2007 | OSCE | CERAGENIX PHARMACE ... | Bautista Alberto J | Director | Option Exercise | A | 1.83 | 48,000 | 87,840 | 48,000 | |
Jun 08 2007 | OSCE | CERAGENIX PHARMACE ... | ALLEN RUSSELL L | Vice President | Option Exercise | A | 1.83 | 135,000 | 247,050 | 135,000 | |
May 11 2007 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Sell | S | 1.65 | 50,000 | 82,500 | 10,991,768 | 11 M to 11 M (-0.45 %) |
Apr 04 2007 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Option Exercise | J | 2.18 | 50,000 | 109,000 | 1,007,161 | |
Sep 08 2006 | OSCE | CERAGENIX PHARMACE ... | Porter Steven | Chief Executive Off ... | Option Exercise | A | 2.25 | 95,200 | 214,200 | 95,200 | |
Sep 08 2006 | OSCE | CERAGENIX PHARMACE ... | Gastone Philippe | Director | Option Exercise | A | 2.25 | 33,000 | 74,250 | 33,000 | |
Sep 08 2006 | OSCE | CERAGENIX PHARMACE ... | GENBERG CARL | Senior Vice Preside ... | Option Exercise | A | 2.25 | 90,200 | 202,950 | 90,200 | |
Sep 08 2006 | OSCE | CERAGENIX PHARMACE ... | Hoffman Bray Cheryl A | Director | Option Exercise | A | 2.25 | 33,000 | 74,250 | 33,000 | |
Sep 08 2006 | OSCE | CERAGENIX PHARMACE ... | Darnaud Michel | Director | Option Exercise | A | 2.25 | 30,000 | 67,500 | 30,000 | |
Sep 08 2006 | OSCE | CERAGENIX PHARMACE ... | Elias Peter | Chief Scientific Of ... | Option Exercise | A | 2.25 | 44,000 | 99,000 | 44,000 | |
Sep 08 2006 | OSCE | CERAGENIX PHARMACE ... | Sperber Jeffrey S | Chief Financial Off ... | Option Exercise | A | 2.25 | 85,300 | 191,925 | 85,300 | |
Sep 08 2006 | OSCE | CERAGENIX PHARMACE ... | Bautista Alberto J | Director | Option Exercise | A | 2.25 | 30,000 | 67,500 | 30,000 | |
Aug 22 2006 | OSCE | CERAGENIX PHARMACE ... | ALLEN RUSSELL L | VP Corporate Develo ... | Option Exercise | P | 2.25 | 85,300 | 191,925 | 85,300 | |
Aug 22 2006 | OSCE | CERAGENIX PHARMACE ... | ALLEN RUSSELL L | VP Corporate Develo ... | Option Exercise | P | 3.80 | 250,000 | 950,000 | 250,000 | |
Aug 22 2006 | OSCE | CERAGENIX PHARMACE ... | ALLEN RUSSELL L | VP Corporate Develo ... | Buy | P | 2.10 | 10,000 | 21,000 | 10,200 | 200 to 10.2 K (+5,000.00 %) |
May 12 2006 | OSCE | CERAGENIX PHARMACE ... | OSMOTICS CORP | 10% Owner | Sell | S | 2.00 | 150,000 | 300,000 | 11,041,768 | 11.2 M to 11 M (-1.34 %) |
Mar 18 2005 | OSCE | CERAGENIX PHARMACE ... | Cochran Jack E | Director | Option Exercise | A | 0.50 | 10,000 | 5,000 | 10,000 | |
Mar 18 2005 | OSCE | CERAGENIX PHARMACE ... | Cochran Jack E | Director | Buy | M | 0.50 | 10,000 | 5,000 | 10,000 | 0 to 10 K |
Feb 28 2005 | OSCE | CERAGENIX PHARMACE ... | OVERTURF JOHN R JR | Director | Option Exercise | A | 0.50 | 10,000 | 5,000 | 10,000 | |
Feb 28 2005 | OSCE | CERAGENIX PHARMACE ... | OVERTURF JOHN R JR | Director | Buy | M | 0.50 | 10,000 | 5,000 | 24,500 | 14.5 K to 24.5 K (+68.97 %) |
Oct 26 2004 | OSCE | CERAGENIX PHARMACE ... | OVERTURF JOHN R JR | Director | Buy | P | 0.60 | 2,700 | 1,620 | 14,700 | 12 K to 14.7 K (+22.50 %) |
Jun 22 2004 | OSCE | CERAGENIX PHARMACE ... | JENNINGS FRANK L | President | Option Exercise | M | 0.50 | 10,000 | 5,000 | 0 | |
Jun 22 2004 | OSCE | CERAGENIX PHARMACE ... | JENNINGS FRANK L | President | Option Exercise | M | 0.50 | 25,000 | 12,500 | 0 | |
Jun 22 2004 | OSCE | CERAGENIX PHARMACE ... | JENNINGS FRANK L | President | Buy | M | 0.50 | 35,000 | 17,500 | 55,000 | 20 K to 55 K (+175.00 %) |
Jun 07 2004 | OSCE | CERAGENIX PHARMACE ... | NEUMAN CLIFFORD L ESQ | Option Exercise | M | 0.50 | 25,000 | 12,500 | 0 | ||
Jun 07 2004 | OSCE | CERAGENIX PHARMACE ... | NEUMAN CLIFFORD L ESQ | Sell | M | 0.50 | 25,000 | 12,500 | 55,500 | 80.5 K to 55.5 K (-31.06 %) |
Page: 1